LIST OF TABLES
TABLE 01.GLOBAL ORAL ANTIBIOTICS MARKET, BY CLASS, 2018-2027 ($MILLION)
TABLE 02.BETA LACTAM & BETA LACTAMASE INHIBITORS ANTIBIOTICS MARKET, BY TYPE, 2018-2027 ($MILLION)
TABLE 03.PENICILLIN ORAL ANTIBIOTICS MARKET, BY TYPE, 2018-2027 ($MILLION)
TABLE 04.ORAL ANTIBIOTICS MARKET FOR CEPHALOSPORIN, BY MOLECULE, 2018-2027 ($MILLION)
TABLE 05.ANTIBIOTICS MARKET FOR BETA LACTAM AND BETA LACTAMASE INHIBITORS, BY REGION, 2018-2027 ($MILLION)
TABLE 06.ANTIBIOTICS MARKET FOR QUINOLONES, BY REGION, 2018-2027 ($MILLION)
TABLE 07.ANTIBIOTICS MARKET FOR MACROLIDES, BY REGION, 2018-2027 ($MILLION)
TABLE 08.ANTIBIOTICS MARKET FOR OTHER CLASSES BY REGION, 2018-2027 ($MILLION)
TABLE 09.GLOBAL ORAL ANTIBIOTICS MARKET, BY APPLICATION, 2018-2027 ($MILLION)
TABLE 10.ORAL ANTIBIOTICS MARKET FOR COMMUNITY-ACQUIRED RESPIRATORY TRACT INFECTIONS, BY TYPE, 2018-2027 ($MILLION)
TABLE 11.ORAL ANTIBIOTICS MARKET FOR UPPER RESPIRATORY TRACT INFECTIONS, BY MOLECULE, 2018-2027 ($MILLION)
TABLE 12.ORAL ANTIBIOTICS MARKET FOR LOWER RESPIRATORY TRACT INFECTIONS, BY MOLECULE, 2018-2027 ($MILLION)
TABLE 13.ORAL ANTIBIOTICS MARKET FOR COMMUNITY-ACQUIRED RESPIRATORY TRACT INFECTIONS, BY REGION, 2018-2027 ($MILLION)
TABLE 14.ORAL ANTIBIOTICS MARKET FOR URINARY TRACT INFECTIONS, BY MOLECULE, 2018-2027 ($MILLION)
TABLE 15.ORAL ANTIBIOTICS MARKET FOR URINARY TRACT INFECTIONS, BY REGION, 2018-2027 ($MILLION)
TABLE 16.ORAL ANTIBIOTICS MARKET FOR DENTAL, BY TYPE, 2018-2027 ($MILLION)
TABLE 17.ORAL ANTIBIOTICS MARKET FOR DENTAL COMBINATION ORAL ANTIBIOTICS, BY MOLECULE, 2018-2027 ($MILLION)
TABLE 18.ORAL ANTIBIOTICS MARKET FOR DENTAL MONOTHERAPIES, BY MOLECULE, 2018-2027 ($MILLION)
TABLE 19.ORAL ANTIBIOTICS MARKET FOR DENTAL, BY REGION, 2018-2027 ($MILLION)
TABLE 20.ORAL ANTIBIOTICS MARKET FOR OTHERS, BY REGION, 2018-2027 ($MILLION)
TABLE 21.GLOBAL ORAL ANTIBIOTICS MARKET, BY DRUG ORIGIN, 2018-2027 ($MILLION)
TABLE 22.ORAL ANTIBIOTICS MARKET FOR NATURAL, BY REGION, 2018-2027 ($MILLION)
TABLE 23.ORAL ANTIBIOTICS MARKET FOR SEMISYNTHETIC, BY REGION, 2018-2027 ($MILLION)
TABLE 24.ORAL ANTIBIOTICS MARKET FOR SYNTHETIC, BY REGION, 2018-2027 ($MILLION)
TABLE 25.GLOBAL ORAL ANTIBIOTICS MARKET, BY SPECTRUM OF ACTIVITY, 2018-2027 ($MILLION)
TABLE 26.ORAL ANTIBIOTICS MARKET FOR BROAD-SPECTRUM ORAL ANTIBIOTIC, BY REGION, 2018-2027 ($MILLION)
TABLE 27.ORAL ANTIBIOTICS MARKET FOR MID/NARROW-SPECTRUM ORAL ANTIBIOTIC, BY REGION, 2018-2027 ($MILLION)
TABLE 28.GLOBAL ORAL ANTIBIOTICS MARKET, BY DRUG TYPE, 2018-2027 ($MILLION)
TABLE 29.BRANDED ANTIBIOTICS MARKET, BY REGION, 2018-2027 ($MILLION)TABLE 30.GENERIC ANTIBIOTICS MARKET, BY REGION, 2018-2027 ($MILLION)
TABLE 31.ORAL ANTIBIOTICS MARKET REVENUE, BY REGION, 2019-2027 ($MILLION)
TABLE 32.NORTH AMERICA ANTIBIOTICS MARKET, BY COUNTRY, 2018-2027 ($MILLION)
TABLE 33.U.S. ORAL ANTIBIOTICS MARKET, BY CLASS, 2018-2027 ($MILLION)
TABLE 34.U.S. ORAL ANTIBIOTICS MARKET, BY APPLICATION, 2018-2027 ($MILLION)
TABLE 35.U.S. ORAL ANTIBIOTICS MARKET, BY DRUG ORIGIN, 2018-2027 ($MILLION)
TABLE 36.U.S. ORAL ANTIBIOTICS MARKET, BY SPECTRUM OF ACTIVITY, 2018-2027 ($MILLION)
TABLE 37.U.S. ORAL ANTIBIOTICS MARKET, BY DRUG TYPE, 2018-2027 ($MILLION)
TABLE 38.CANADA ORAL ANTIBIOTICS MARKET, BY CLASS, 2018-2027 ($MILLION)
TABLE 39.CANADA ORAL ANTIBIOTICS MARKET, BY APPLICATION, 2018-2027 ($MILLION)
TABLE 40.CANADA ORAL ANTIBIOTICS MARKET, BY DRUG ORIGIN, 2018-2027 ($MILLION)
TABLE 41.CANADA ORAL ANTIBIOTICS MARKET, BY SPECTRUM OF ACTIVITY, 2018-2027 ($MILLION)
TABLE 42.CANADA ORAL ANTIBIOTICS MARKET, BY DRUG TYPE, 2018-2027 ($MILLION)
TABLE 43.MEXICO ORAL ANTIBIOTICS MARKET, BY CLASS, 2018-2027 ($MILLION)
TABLE 44.MEXICO ORAL ANTIBIOTICS MARKET, BY APPLICATION, 2018-2027 ($MILLION)
TABLE 45.MEXICO ORAL ANTIBIOTICS MARKET, BY DRUG ORIGIN, 2018-2027 ($MILLION)
TABLE 46.MEXICO ORAL ANTIBIOTICS MARKET, BY SPECTRUM OF ACTIVITY, 2018-2027 ($MILLION)
TABLE 47.MEXICO ORAL ANTIBIOTICS MARKET, BY DRUG TYPE, 2018-2027 ($MILLION)
TABLE 48.NORTH AMERICA ORAL ANTIBIOTICS MARKET, BY CLASS, 2018-2027 ($MILLION)
TABLE 49.NORTH AMERICA ORAL ANTIBIOTICS MARKET, BY APPLICATION, 2018-2027 ($MILLION)
TABLE 50.NORTH AMERICA ORAL ANTIBIOTICS MARKET, BY DRUG ORIGIN, 2018-2027 ($MILLION)
TABLE 51.NORTH AMERICA ORAL ANTIBIOTICS MARKET, BY SPECTRUM OF ACTIVITY, 2018-2027 ($MILLION)
TABLE 52.NORTH AMERICA ANTIBIOTICS MARKET, BY DRUG TYPE, 2018-2027 ($MILLION)
TABLE 53.EUROPE ORAL ANTIBIOTICS MARKET, BY COUNTRY, 2018-2027 ($MILLION)
TABLE 54.GERMANY ORAL ANTIBIOTICS MARKET, BY CLASS, 2018-2027 ($MILLION)
TABLE 55.GERMANY ORAL ANTIBIOTICS MARKET, BY APPLICATION, 2018-2027 ($MILLION)
TABLE 56.GERMANY ORAL ANTIBIOTICS MARKET, BY DRUG ORIGIN, 2018-2027 ($MILLION)
TABLE 57.GERMANY ORAL ANTIBIOTICS MARKET, BY SPECTRUM OF ACTIVITY, 2018-2027 ($MILLION)
TABLE 58.GERMANY ORAL ANTIBIOTICS MARKET, BY DRUG TYPE, 2018-2027 ($MILLION)
TABLE 59.FRANCE ORAL ANTIBIOTICS MARKET, BY CLASS, 2018-2027 ($MILLION)
TABLE 60.FRANCE ORAL ANTIBIOTICS MARKET, BY APPLICATION, 2018-2027 ($MILLION)
TABLE 61.FRANCE ORAL ANTIBIOTICS MARKET, BY DRUG ORIGIN, 2018-2027 ($MILLION)
TABLE 62.FRANCE ORAL ANTIBIOTICS MARKET, BY SPECTRUM OF ACTIVITY, 2018-2027 ($MILLION)
TABLE 63.FRANCE ORAL ANTIBIOTICS MARKET, BY DRUG TYPE, 2018-2027 ($MILLION)
TABLE 64.SPAIN ORAL ANTIBIOTICS MARKET, BY CLASS, 2018-2027 ($MILLION)
TABLE 65.SPAIN ORAL ANTIBIOTICS MARKET, BY APPLICATION, 2018-2027 ($MILLION)
TABLE 66.SPAIN ORAL ANTIBIOTICS MARKET, BY DRUG ORIGIN, 2018-2027 ($MILLION)
TABLE 67.SPAIN ORAL ANTIBIOTICS MARKET, BY SPECTRUM OF ACTIVITY, 2018-2027 ($MILLION)
TABLE 68.SPAIN ORAL ANTIBIOTICS MARKET, BY DRUG TYPE, 2018-2027 ($MILLION)
TABLE 69.ITALY ORAL ANTIBIOTICS MARKET, BY CLASS, 2018-2027 ($MILLION)
TABLE 70.ITALY ORAL ANTIBIOTICS MARKET, BY APPLICATION, 2018-2027 ($MILLION)
TABLE 71.ITALY ORAL ANTIBIOTICS MARKET, BY DRUG ORIGIN, 2018-2027 ($MILLION)
TABLE 72.ITALY ORAL ANTIBIOTICS MARKET, BY SPECTRUM OF ACTIVITY, 2018-2027 ($MILLION)
TABLE 73.ITALY ORAL ANTIBIOTICS MARKET, BY DRUG TYPE, 2018-2027 ($MILLION)
TABLE 74.UK ORAL ANTIBIOTICS MARKET, BY CLASS, 2018-2027 ($MILLION)
TABLE 75.UK ORAL ANTIBIOTICS MARKET, BY APPLICATION, 2018-2027 ($MILLION)
TABLE 76.UK ORAL ANTIBIOTICS MARKET, BY DRUG ORIGIN, 2018-2027 ($MILLION)
TABLE 77.UK ORAL ANTIBIOTICS MARKET, BY SPECTRUM OF ACTIVITY, 2018-2027 ($MILLION)
TABLE 78.UK ORAL ANTIBIOTICS MARKET, BY DRUG TYPE, 2018-2027 ($MILLION)
TABLE 79.RUSSIA ORAL ANTIBIOTICS MARKET, BY CLASS, 2018-2027 ($MILLION)
TABLE 80.RUSSIA ORAL ANTIBIOTICS MARKET, BY APPLICATION, 2018-2027 ($MILLION)
TABLE 81.RUSSIA ORAL ANTIBIOTICS MARKET, BY DRUG ORIGIN, 2018-2027 ($MILLION)
TABLE 82.RUSSIA ORAL ANTIBIOTICS MARKET, BY SPECTRUM OF ACTIVITY, 2018-2027 ($MILLION)
TABLE 83.RUSSIA ORAL ANTIBIOTICS MARKET, BY DRUG TYPE, 2018-2027 ($MILLION)
TABLE 84.REST OF EUROPE ORAL ANTIBIOTICS MARKET, BY CLASS, 2018-2027 ($MILLION)
TABLE 85.REST OF EUROPE ORAL ANTIBIOTICS MARKET, BY APPLICATION, 2018-2027 ($MILLION)
TABLE 86.REST OF EUROPE ORAL ANTIBIOTICS MARKET, BY DRUG ORIGIN, 2018-2027 ($MILLION)
TABLE 87.REST OF EUROPE ORAL ANTIBIOTICS MARKET, BY SPECTRUM OF ACTIVITY, 2018-2027 ($MILLION)
TABLE 88.REST OF EUROPE ORAL ANTIBIOTICS MARKET, BY DRUG TYPE, 2018-2027 ($MILLION)
TABLE 89.EUROPE ORAL ANTIBIOTICS MARKET, BY CLASS, 2018-2027 ($MILLION)
TABLE 90.EUROPE ORAL ANTIBIOTICS MARKET, BY APPLICATION, 2018-2027 ($MILLION)
TABLE 91.EUROPE ORAL ANTIBIOTICS MARKET, BY DRUG ORIGIN, 2018-2027 ($MILLION)
TABLE 92.EUROPE ORAL ANTIBIOTICS MARKET, BY SPECTRUM OF ACTIVITY, 2018-2027 ($MILLION)
TABLE 93.EUROPE ORAL ANTIBIOTICS MARKET, BY DRUG TYPE, 2018-2027 ($MILLION)
TABLE 94.ASIA-PACIFIC ORAL ANTIBIOTICS MARKET, BY COUNTRY, 2018-2027 ($MILLION)
TABLE 95.JAPAN ORAL ANTIBIOTICS MARKET, BY CLASS, 2018-2027 ($MILLION)
TABLE 96.JAPAN ORAL ANTIBIOTICS MARKET, BY APPLICATION, 2018-2027 ($MILLION)
TABLE 97.JAPAN ORAL ANTIBIOTICS MARKET, BY DRUG ORIGIN, 2018-2027 ($MILLION)
TABLE 98.JAPAN ORAL ANTIBIOTICS MARKET, BY SPECTRUM OF ACTIVITY, 2018-2027 ($MILLION)
TABLE 99.JAPAN ORAL ANTIBIOTICS MARKET, BY DRUG TYPE, 2018-2027 ($MILLION)
TABLE 100.INDIA ORAL ANTIBIOTICS MARKET, BY CLASS, 2018-2027 ($MILLION)
TABLE 101.INDIA ORAL ANTIBIOTICS MARKET, BY APPLICATION, 2018-2027 ($MILLION)
TABLE 102.INDIA ORAL ANTIBIOTICS MARKET, BY DRUG ORIGIN, 2018-2027 ($MILLION)
TABLE 103.INDIA ORAL ANTIBIOTICS MARKET, BY SPECTRUM OF ACTIVITY, 2018-2027 ($MILLION)
TABLE 104.INDIA ORAL ANTIBIOTICS MARKET, BY DRUG TYPE, 2018-2027 ($MILLION)
TABLE 105.CHINA ORAL ANTIBIOTICS MARKET, BY CLASS, 2018-2027 ($MILLION)
TABLE 106.CHINA ORAL ANTIBIOTICS MARKET, BY APPLICATION, 2018-2027 ($MILLION)
TABLE 107.CHINA ORAL ANTIBIOTICS MARKET, BY DRUG ORIGIN, 2018-2027 ($MILLION)
TABLE 108.CHINA ORAL ANTIBIOTICS MARKET, BY SPECTRUM OF ACTIVITY, 2018-2027 ($MILLION)
TABLE 109.CHINA ORAL ANTIBIOTICS MARKET, BY DRUG TYPE, 2018-2027 ($MILLION)
TABLE 110.PAKISTAN ORAL ANTIBIOTICS MARKET, BY CLASS, 2018-2027 ($MILLION)
TABLE 111.PAKISTAN ORAL ANTIBIOTICS MARKET, BY APPLICATION, 2018-2027 ($MILLION)
TABLE 112.PAKISTAN ORAL ANTIBIOTICS MARKET, BY DRUG ORIGIN, 2018-2027 ($MILLION)
TABLE 113.PAKISTAN ORAL ANTIBIOTICS MARKET, BY SPECTRUM OF ACTIVITY, 2018-2027 ($MILLION)
TABLE 114.PAKISTAN ORAL ANTIBIOTICS MARKET, BY DRUG TYPE, 2018-2027 ($MILLION)
TABLE 115.VIETNAM ORAL ANTIBIOTICS MARKET, BY CLASS, 2018-2027 ($MILLION)
TABLE 116.VIETNAM ORAL ANTIBIOTICS MARKET, BY APPLICATION, 2018-2027 ($MILLION)
TABLE 117.VIETNAM ORAL ANTIBIOTICS MARKET, BY DRUG ORIGIN, 2018-2027 ($MILLION)
TABLE 118.VIETNAM ORAL ANTIBIOTICS MARKET, BY SPECTRUM OF ACTIVITY, 2018-2027 ($MILLION)
TABLE 119.VIETNAM ORAL ANTIBIOTICS MARKET, BY DRUG TYPE, 2018-2027 ($MILLION)
TABLE 120.REST OF ASIA-PACIFIC ORAL ANTIBIOTICS MARKET, BY CLASS, 2018-2027 ($MILLION)
TABLE 121.REST OF ASIA-PACIFIC ORAL ANTIBIOTICS MARKET, BY APPLICATION, 2018-2027 ($MILLION)
TABLE 122.REST OF ASIA-PACIFIC ORAL ANTIBIOTICS MARKET, BY DRUG ORIGIN, 2018-2027 ($MILLION)
TABLE 123.REST OF ASIA-PACIFIC ORAL ANTIBIOTICS MARKET, BY SPECTRUM OF ACTIVITY, 2018-2027 ($MILLION)
TABLE 124.REST OF ASIA-PACIFIC ORAL ANTIBIOTICS MARKET, BY DRUG TYPE, 2018-2027 ($MILLION)
TABLE 125.ASIA-PACIFIC ORAL ANTIBIOTICS MARKET, BY CLASS, 2018-2027 ($MILLION)
TABLE 126.ASIA-PACIFIC ORAL ANTIBIOTICS MARKET, BY APPLICATION, 2018-2027 ($MILLION)
TABLE 127.ASIA-PACIFIC ORAL ANTIBIOTICS MARKET, BY DRUG ORIGIN, 2018-2027 ($MILLION)
TABLE 128.ASIA-PACIFIC ORAL ANTIBIOTICS MARKET, BY SPECTRUM OF ACTIVITY, 2018-2027 ($MILLION)
TABLE 129.ASIA-PACIFIC ORAL ANTIBIOTICS MARKET, BY DRUG TYPE, 2018-2027 ($MILLION)
TABLE 130.LAMEA ANTIBIOTICS MARKET, BY COUNTRY, 2018-2027 ($MILLION)
TABLE 131.BRAZIL ORAL ANTIBIOTICS MARKET, BY CLASS, 2018-2027 ($MILLION)
TABLE 132.BRAZIL ORAL ANTIBIOTICS MARKET, BY APPLICATION, 2018-2027 ($MILLION)
TABLE 133.BRAZIL ORAL ANTIBIOTICS MARKET, BY DRUG ORIGIN, 2018-2027 ($MILLION)
TABLE 134.BRAZIL ORAL ANTIBIOTICS MARKET, BY SPECTRUM OF ACTIVITY, 2018-2027 ($MILLION)
TABLE 135.BRAZIL ORAL ANTIBIOTICS MARKET, BY DRUG TYPE, 2018-2027 ($MILLION)
TABLE 136.SAUDI ARABIA ORAL ANTIBIOTICS MARKET, BY CLASS, 2018-2027 ($MILLION)
TABLE 137.SAUDI ARABIA ORAL ANTIBIOTICS MARKET, BY APPLICATION, 2018-2027 ($MILLION)
TABLE 138.SAUDI ARABIA ORAL ANTIBIOTICS MARKET, BY DRUG ORIGIN, 2018-2027 ($MILLION)
TABLE 139.SAUDI ARABIA ORAL ANTIBIOTICS MARKET, BY SPECTRUM OF ACTIVITY, 2018-2027 ($MILLION)
TABLE 140.SAUDI ARABIA ORAL ANTIBIOTICS MARKET, BY APPLICATION, 2018-2027 ($MILLION)
TABLE 141.SOUTH AFRICA ORAL ANTIBIOTICS MARKET, BY CLASS, 2018-2027 ($MILLION)
TABLE 142.SOUTH AFRICA ORAL ANTIBIOTICS MARKET, BY APPLICATION, 2018-2027 ($MILLION)
TABLE 143.SOUTH AFRICA ORAL ANTIBIOTICS MARKET, BY DRUG ORIGIN, 2018-2027 ($MILLION)
TABLE 144.SOUTH AFRICA ORAL ANTIBIOTICS MARKET, BY SPECTRUM OF ACTIVITY, 2018-2027 ($MILLION)
TABLE 145.SOUTH AFRICA ORAL ANTIBIOTICS MARKET, BY DRUG TYPE, 2018-2027 ($MILLION)
TABLE 146.TURKEY ORAL ANTIBIOTICS MARKET, BY CLASS, 2018-2027 ($MILLION)
TABLE 147.TURKEY ORAL ANTIBIOTICS MARKET, BY APPLICATION, 2018-2027 ($MILLION)
TABLE 148.TURKEY ORAL ANTIBIOTICS MARKET, BY DRUG ORIGIN, 2018-2027 ($MILLION)
TABLE 149.TURKEY ORAL ANTIBIOTICS MARKET, BY SPECTRUM OF ACTIVITY, 2018-2027 ($MILLION)
TABLE 150.TURKEY ORAL ANTIBIOTICS MARKET, BY DRUG TYPE, 2018-2027 ($MILLION)
TABLE 151.REST OF LAMEA ORAL ANTIBIOTICS MARKET, BY CLASS, 2018-2027 ($MILLION)
TABLE 152.REST OF LAMEA ORAL ANTIBIOTICS MARKET, BY APPLICATION, 2018-2027 ($MILLION)
TABLE 153.REST OF LAMEA ORAL ANTIBIOTICS MARKET, BY DRUG ORIGIN, 2018-2027 ($MILLION)
TABLE 154.REST OF LAMEA ORAL ANTIBIOTICS MARKET, BY SPECTRUM OF ACTIVITY, 2018-2027 ($MILLION)
TABLE 155.REST OF LAMEA ORAL ANTIBIOTICS MARKET, BY DRUG TYPE, 2018-2027 ($MILLION)
TABLE 156.LAMEA ANTIBIOTICS MARKET, BY CLASS, 2018-2027 ($MILLION)
TABLE 157.LAMEA ANTIBIOTICS MARKET, BY APPLICATION, 2018-2027 ($MILLION)
TABLE 158.LAMEA ANTIBIOTICS MARKET, BY DRUG ORIGIN, 2018-2027 ($MILLION)
TABLE 159.LAMEA ANTIBIOTICS MARKET, BY SPECTRUM OF ACTIVITY, 2018-2027 ($MILLION)
TABLE 160.LAMEA ANTIBIOTICS MARKET, BY DRUG TYPE, 2018-2027 ($MILLION)
TABLE 161.ABBOTT: COMPANY SNAPSHOT
TABLE 162.ABBOTT: OERATING SEGMENT
TABLE 163.ABBOTT: PRODUCT PORTFOLIO
TABLE 164.ALLERGAN: COMPANY SNAPSHOT
TABLE 165.ALLERGAN: OPERATING SEGMENTS
TABLE 166.ALLERGAN: PRODUCT PORTFOLIO
TABLE 167.ROCHE: COMPANY SNAPSHOT
TABLE 168.ROCHE: OERATING SEGMENT
TABLE 169.ROCHE: PRODUCT PORTFOLIO
TABLE 170.GSK: COMPANY SNAPSHOT
TABLE 171.GSK: OPERATING SEGMENTS
TABLE 172.GSK: PRODUCT PORTFOLIO
TABLE 173.MERCK: COMPANY SNAPSHOT
TABLE 174.MERCK: OPERATING SEGMENTS
TABLE 175.MERCK PRODUCT PORTFOLIO
TABLE 176.MYLAN: COMPANY SNAPSHOT
TABLE 177.MYLAN: OPERATING SEGMENTS
TABLE 178.ALLERGAN: PRODUCT PORTFOLIO
TABLE 179.NOVARTIS: COMPANY SNAPSHOT
TABLE 180.NOVARTIS: OPERATING SEGMENTS
TABLE 181.NOVARTIS: PRODUCT PORTFOLIO
TABLE 182.PFIZER: COMPANY SNAPSHOT
TABLE 183.PFIZER: OPERATING SEGMENTS
TABLE 184.PFIZER: PRODUCT PORTFOLIO
TABLE 185.SANOFI: COMPANY SNAPSHOT
TABLE 186.SANOFI: OPERATING SEGMENTS
TABLE 187.SANOFI: PRODUCT PORTFOLIO
TABLE 188.TEVA: COMPANY SNAPSHOT
TABLE 189.TEVA: OPERATING SEGMENTS
TABLE 190.TEVA: PRODUCT PORTFOLIO
LIST OF FIGURE
LIST OF FIGURES
FIGURE 01.ORAL ANTIBIOTICS MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS IN THE GLOBAL ORAL ANTIBIOTICS MARKET
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2017-2020*
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017-2020* (%)
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2017-2020*
FIGURE 06.MARKET SHARE ANALYSIS, 2018
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 09.LOW THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE THREAT OF SUBSTITUTIONS
FIGURE 11.HIGH COMPETITIVE RIVALRY
FIGURE 12.BROAD-SPECTRUM PENICILLIN MARKET, 2018-2027 ($MILLION)
FIGURE 13.MID/NARROW-SPECTRUM PENICILLIN MARKET, 2018-2027 ($MILLION)
FIGURE 14.CEPHALOSPORIN ANTIBIOTICS MARKET, 2018-2027 ($MILLION)
FIGURE 15.OTHER BETA LACTAM & BETA LACTAMASE INHIBITORS ANTIBIOTICS MARKET, 2018-2027 ($MILLION)
FIGURE 16.COMPARATIVE ANALYSIS OF ANTIBIOTICS MARKET FOR BETA LACTAM AND BETA LACTAMASE INHIBITORS, BY COUNTRY, 2018 & 2027 ($MILLION)
FIGURE 17.COMPARATIVE ANALYSIS OF ANTIBIOTICS MARKET FOR QUINOLONES, BY COUNTRY, 2018 & 2027 ($MILLION)
FIGURE 18.COMPARATIVE ANALYSIS OF ANTIBIOTICS MARKET FOR MACROLIDES, BY COUNTRY, 2018 & 2027 ($MILLION)
FIGURE 19.COMPARATIVE ANALYSIS OF ANITBIOTICS MARKET FOR OTHERS, BY COUNTRY, 2018 & 2027 ($MILLION)
FIGURE 20.ORAL ANTIBIOTICS MARKET FOR UPPER RESPIRATORY TRACT INFECTIONS, 2018-2027 ($MILLION)
FIGURE 21.ORAL ANTIBIOTICS MARKET FOR LOWER RESPIRATORY TRACT INFECTIONS, 2018-2027 ($MILLION)
FIGURE 22.COMPARATIVE ANALYSIS OF ORAL ANTIBIOTICS MARKET FOR COMMUNITY-ACQUIRED RESPIRATORY TRACT INFECTIONS, BY COUNTRY, 2018 & 2027 ($MILLION)
FIGURE 23.COMPARATIVE ANALYSIS OF ORAL ANTIBIOTICS MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2018 & 2027 ($MILLION)
FIGURE 24.ORAL ANTIBIOTICS MARKET FOR DENTAL, BY COMBINATION, 2018-2027 ($MILLION)
FIGURE 25.ORAL ANTIBIOTICS MARKET FOR DENTAL, BY MONOTHERAPIES, 2018-2027 ($MILLION)
FIGURE 26.COMPARATIVE ANALYSIS OF ORAL ANTIBIOTICS MARKET FOR DENTAL, BY COUNTRY, 2018 & 2027 ($MILLION)
FIGURE 27.COMPARATIVE ANALYSIS OF ORAL ANTIBIOTICS MARKET FOR OTHERS, BY COUNTRY, 2018 & 2027 ($MILLION)
FIGURE 28.COMPARATIVE ANALYSIS OF ORAL ANTIBIOTICS MARKET FOR NATURAL, BY COUNTRY, 2018 & 2027 ($MILLION)
FIGURE 29.COMPARATIVE ANALYSIS OF ORAL ANTIBIOTICS MARKET FOR SEMISYNTHETIC, BY COUNTRY, 2018 & 2027 ($MILLION)
FIGURE 30.COMPARATIVE ANALYSIS OF ORAL ANTIBIOTICS MARKET FOR SYNTHETIC, BY COUNTRY, 2018 & 2027 ($MILLION)
FIGURE 31.COMPARATIVE ANALYSIS OF ORAL ANTIBIOTICS MARKET FOR BROAD-SPECTRUM ORAL ANTIBIOTIC, BY COUNTRY, 2018 & 2027 ($MILLION)
FIGURE 32.COMPARATIVE ANALYSIS OF ORAL ANTIBIOTICS MARKET FOR MID/NARROW-SPECTRUM ORAL ANTIBIOTIC, BY COUNTRY, 2018 & 2027 ($MILLION)
FIGURE 33.COMPARATIVE ANALYSIS OF BRANDED ORAL ANTIBIOTICS MARKET, BY COUNTRY, 2018 & 2027 ($MILLION)
FIGURE 34.COMPARATIVE ANALYSIS OF GENERIC ORAL ANTIBIOTICS MARKET, BY COUNTRY, 2018 & 2027 ($MILLION)
FIGURE 35.ABBOTT: NET SALES, 2017-2019 ($MILLION)
FIGURE 36.ABBOTT: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 37.ABBOTT: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 38.ALLERGAN: NET SALES, 2017-2019 ($MILLION)
FIGURE 39.ALLERGAN: REVENUE SHARE, BY SEGMENT, 2019(%)
FIGURE 40.ROCHE: NET SALES, 2017-2019 ($MILLION)
FIGURE 41.ROCHE: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 42.ROCHE: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 43.GSK: NET SALES, 2017-2019 ($MILLION)
FIGURE 44.GSK: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 45.GSK: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 46.MERCK: NET SALES, 2017-2019 ($MILLION)
FIGURE 47.MERCK: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 48.MERCK: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 49.MYLAN: NET SALES, 2017-2019 ($MILLION)
FIGURE 50.MYLAN: REVENUE SHARE, BY REGION, 2017 (%)
FIGURE 51.NOVARTIS: NET SALES, 2017-2019 ($MILLION)
FIGURE 52.NOVARTIS: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 53.NOVARTIS: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 54.PFIZER: NET SALES, 2017-2019 ($MILLION)
FIGURE 55.PFIZER: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 56.PFIZER: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 57.SANOFI: NET SALES, 2017-2019 ($MILLION)
FIGURE 58.SANOFI: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 59.SANOFI: REVENUE SHARE, BY REGION, 2019(%)
FIGURE 60.TEVA: NET SALES, 2017-2019 ($MILLION)
FIGURE 61.TEVA: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 62.TEVA: REVENUE SHARE, BY REGION, 2019 (%)
